Invesco Biotechnology & Genome ETF
Limited financial coverage for PBE.
Not enough data to compute a meaningful composite — typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available stats still render below.
About the company
The Invesco Biotechnology & Genome ETF (PBE) seeks to replicate the performance of the Dynamic Biotech & Genome Intellidex Index. This fund typically allocates a minimum of 90% of its total assets to the securities comprising the underlying index. The Index is constructed to achieve capital appreciation by thoroughly evaluating companies based on several investment criteria, including their price momentum, earnings growth, overall quality, management decisions, and valuation.
- IPO
- 2005
- HQ
- Houston, TX, US
Price Chart
- Market Cap
- $265.45M
- Div Yield
- 1.68%
- 52W High
- $92.14
- 52W Low
- $63.92
- 50D MA
- $83.10
- 200D MA
- $79.57
- Beta
- 0.81
- Avg Volume
- 5.80K
Get TickerSpark's AI analysis on PBE
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our PBE coverage
Recent articles, reports, and earnings notes.
No research on PBE yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate PBE report →Similar companies
Peers in the same neighborhood.